http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2493255-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28cecfc87bfdb41e74447f4815647949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c86eb25ee468649f78909193fd13760 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57 |
| filingDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de85334467afba4332193af49f881f8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fad6093a71b931657d5e42a676a52a6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8866a560f9de0835b8bd1ee4a6a2ebea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b111ef387dab8490c263ff3837dcd8 |
| publicationDate | 2013-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2493255-C2 |
| titleOfInvention | Curtailed secretable aspartyl-proteinase 2 |
| abstract | FIELD: biotechnologies. n SUBSTANCE: invention relates to a polypeptide of curtailed secretable aspartyl-proteinase 2, which is able to efficiently provoke antibody-mediated and cellular immune reactions at C.albicans and containing an amino acid sequence corresponding to SEQ ID NO:1; or a functionally equivalent polypeptide, which has an amino acid sequence produced from the SEQ ID NO:1 by means of one or more conservative substitutions of amino acids, besides, the specified polypeptide at least by 80% is identical to the amino acid sequence SEQ ID NO:1 for the entire length of SEQ ID NO:1. Also a polynucleotide is disclosed, which codes the specified polypeptide, an expression vector comprising the specified polynucleotide, a host cell for production of the specified polypeptide containing the specified vector. Compositions are disclosed for treatment or prevention of the infection Candida albicans, containing the specified polypeptide or polynucleotide in the efficient amount, and also the method for treatment and prevention of the infection Candida albicans using these compositions. Also a set is disclosed for diagnostics of the infection Candida albicans, containing the specified polypeptide and/or the specified polynucleotide and a reagent for detection of complexes that include the specified polypeptide. n EFFECT: invention makes it possible to efficiently provoke antibody-mediated and cellular immune reactions and has no disadvantages available in full-size aspartyl proteinase of wild type. n 18 cl, 7 dwg, 1 tbl |
| priorityDate | 2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1080.